Amarin Corp Plc (AMRN)

[Nukemtiltheyglow]

Thanks lizzy, seems as though money was well spent as Vascepa revenues increased 3 month (43.7%) and 9 month (45.2%).

Encouraging to see Pfizer is still in the picture with the amended promotional services agreement.
Since Pfizer is staying with Vascepa that is definitely a good sign. It's really only a matter of time and better economic conditions.

Interesting side note: Novartis AG developed Clorazil, it's sales slightly dropped, so the improvement in HLS revenues came from Vascepa sales....very encouraging indeed.